National Institute on Drug Abuse
Director's Report to the National Advisory Council on Drug Abuse
NIDA's Genetics Workgroup sponsored a workshop on The Role of Behavior Genetics in NIDA's Vulnerability to Drug Addiction Initiative at the Neuroscience Center on May 27, 1999. Chaired by Dr. Naimah Weinberg, DEPR, this meeting included six outside experts and several NIDA program staff members.
NIDA's Special Populations Office sponsored its annual workshop Cannabinoid, Opiate, and Estrogen Vascular Neuroimmunology, in Melville, New York on June 23-25, 1999. The workshop, which was co-sponsored by the State University at Old Westbury and the Nikon Corporation, offered minority and women investigators opportunities to learn cutting-edge research and methodology in this area, and techniques such as computer-assisted microscopic image analysis. The workshop was chaired by Pamela Goodlow, Special Populations Office, Dr. Joseph Frascella of the Division of Clinical and Services Research, and Dr. George Stefano from SUNY/Old Westbury.
The National Institute on Drug Abuse sponsored a satellite meeting to the AIDS Impact meeting in Ottowa Canada on July 15, 1999 entitled Drug Abuse and AIDS: Intertwined Epidemics. Ms. Helen Cesari, DEPR, Dr. Henry "Skip" Francis, CAMCODA, and Dr. David Shurtleff, DBR chaired the event which was supported by the Center on AIDS and Other Medical Consequences of Drug Abuse (CAMCODA), the Division of Basic Research, the Division of Epidemiology and Prevention Research and by the Behavioral Sciences Workgroup. Drs. Linda Erinoff and David Shurtleff served as co-organizers of the event.
NIDA co-sponsored the Technical Assistance Workshop held July 16, 1999, for 112 applicants applying to RFA OD-99-006 Research on Child Neglect sponsored by the NIH Child Abuse and Neglect Working Group and Consortium. In addition to institutes within NIH, the Consortium includes the Children's Bureau, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, and the Office of Special Education. Coryl Jones, ERB, DEPR, presented a paper on human subject concerns and methodological issues. Vince Smerglio, CAMCODA, Kathie Etz, PRB, DEPR, and Jacques Normand, CRB, DEPR served as faculty. Applications under the RFA were due September 14, 1999.
The FASEB Summer conference entitled Pulmonary Pathophysiologic and Immune Consequences of Smoked Substance Abuse, partially supported by the National Institute on Drug Abuse, was convened in Copper Mountain, Colorado, July 18-23, 1999. The conference was co-chaired by Dr. Donald P. Tashkin and Dr. Michael Roth of the University of California at Los Angeles and Dr. Pushpa V. Thadani of NIDA's Division of Basic Research.
NIDA's MDD and CAMCODA organized NIDA's first Workshop on Drug-Drug Interactions where nation's leading pharmacologists/pharmacokineticists and clinicians discussed issues on Interactions Between Pharmacotherapeutic Agents Used in the Treatment of AIDS and Drug Addiction. The meeting was held September 9-10, 1999, in the Neuroscience Center.
Contact: Jag Khalsa, Ph.D., CAMCODA.
NIDA staff members Arthur MacNeill Horton, Jr., Ed.D., ECNB, DCSR, Teri Levitin, Ph.D., OEPR, and Vincent Smeriglio, Ph.D., CAMCODA, recently organized a symposium at the April 1999 Meeting of the Society for Research on Child Development in Albuquerque, New Mexico--the premier gathering of child development researchers--as part of NIDA's "Early Career Pathways-Opportunities for Behavioral Researchers" series of events that were held at scientific meetings sponsored by the Behavioral Science Work Group. The SRCD events were also co-sponsored by NIDA's Child and Adolescent Work Group. The first event was a symposium entitled How to Create Your Research Career: Mentoring, Networking and Grant Writing. The symposium brought together NIDA supported early career investigators to discuss their experiences. It provided an interesting look at the opportunities afforded by various NIDA funding mechanisms, as each young investigator was supported by a different mechanism. After Dr. Levitin described the importance of research on child development to NIDA, a senior researcher and three junior/young NIDA-funded investigators presented brief talks. Dr. Jeanne Brooks-Gunn discussed her mentoring activities. The young investigators described how NIDA has facilitated their research careers within the context of their research and current findings. The young investigators were Arnise Johnson of the University of Miami Medical School Department of Pediatrics (Pre-doctoral Minority Supplement), Mark Myers, Ph.D., of the Department of Psychiatry of the University of California at San Diego (FIRST Award) and Lauren Wakschlag, Ph.D., of the Department of Psychiatry of the University of Chicago (B/START). Dr. Lucinda Miner, SPB, OSPC gave an overview of the Institute and delivered a presentation on NIDA's mechanisms for research and career development support.
At the June, 1999 CPDD meeting, MDD held a workshop entitled AEvaluation of Selegiline as a Cocaine Treatment Medication: The Path to a Multi-Site Phase III Trial.@ The meeting was chaired by Dr. Frank Vocci (Director, MDD). Preclinical findings obtained under NIDA=s Cocaine Treatment Discovery Program contracts were presented by Drs. David McCann and Jane B. Acri (MDD Pharmacology and Toxicology Branch) and clinical findings were presented by Dr. Deborah Leiderman (MDD Clinical Trials Branch). Most notably, it was found that selegiline, when administered to rhesus monkeys in a single dose with an appropriately long pretreatment time (24 hours) or by continuous i.v. infusion for several days, can antagonize the subjective and rewarding effects of cocaine (results of cocaine drug discrimination and self-administration experiments). Consonant with the preclinical findings, selegiline caused a significant blunting of cocaine=s subjective effects in man. The effects of selegiline on cocaine use (Phase II study) appeared promising. The design of NIDA's Phase III studies were presented and discussed. Drs. Steve Negus, Nancy Mello, Mike Forster, Jack Bergman and Tom Newton participated as discussants.
The Etiology and Clinical Neurobiology Branch, DCSR sponsored an exhibit booth at the Cognitive Neuroscience Society meeting in Washington, D.C. April 11-13, 1999. NIDA was the first NIH institute to sponsor an exhibit booth at this meeting and has been the sole NIH institute with an exhibit booth for the last 3 years.
The Etiology and Clinical Neurobiology Branch, DCSR, sponsored a booth at the International Society for Magnetic Resonance in Medicine, May 22-28, 1999, in Philadelphia. Drs. Joseph Frascella and Steven Grant attended the meeting. NIDA was the first NIH institute to sponsor an exhibit booth at this meeting.
NIDA's Etiology and Clinical Neurobiology Branch was a co-sponsor with NIMH of the annual Summer Training Institute in Cognitive Neuroscience, held at Dartmouth University, Hanover, NH, June 21-July 8, 1999.
NIDA Director Dr. Alan I. Leshner and Dr. Timothy P. Condon, Associate Director, NIDA, Director, Office of Science Policy and Communications, participated in the launch of the Kmart Foundation-sponsored Kids Race Against Drugs on April 15, 1999 in Los Angeles, CA.
Richard A. Millstein, Deputy Director, NIDA, spoke on "The Future of Drug Courts" at the National Association of Drug Court Professions (NADCP) 5th Annual Conference, Miami Beach, Florida, on June 4, 1999.
Richard A. Millstein, Deputy Director, NIDA, spoke on "Confronting Drug Abuse and HIV/AIDS" at the 20th Anniversary Conference of the Hubert H. Humphrey Fellowship Program, Washnington, D.C., June 18, 1999.
Richard A. Millstein, Deputy Director, NIDA, met with the Steering Committee of the National Hispanic Network on Drug Abuse to discuss program initiatives in Bethesda, Maryland, July 8 and 9, 1999.
Richard A. Millstein, Deputy Director, NIDA, met with the Board of Directors, presented a plenary address, and participated in a research workshop at the 10th Anniversary Conference of the National Asian/Pacific-American Families Against Substance Abuse (NAPAFASA), Los Angeles, CA, July 21-22, 1999.
Dr. Timothy Condon, participated in a meeting of the Inter-Federal Agency Methamphetamine Task Force, May 3-5, 1999 in San Diego, CA.
Dr. Timothy P. Condon made a keynote presentation, "Drugs and the Brain: Implications for Social Work Practitioners," at the annual Social Work and Addictions Conference of the National Association of Social Workers, May 8, 1999 in New York City.
Dr. Timothy P. Condon addressed the American Psychiatric Association's Council on Research and Council on Addictions, May 18 and 19, 1999, in Washington, D.C.
Drs. Timothy P. Condon, Andrea Baruchin, and Lucinda Miner addressed the NIDA Research Training Coordinators at their annual meeting on May 21, 1999 in Bethesda, MD.
Dr. Timothy P. Condon presented a keynote address, "Recent Advanced in Drug Addiction Research" at the annual meeting of the National Association of Alcoholism and Drug Abuse Counselors, May 27, 1999 in Philadelphia, PA.
Dr. Timothy P. Condon presented a keynote address, "Understanding the Science of Addiction" at the NIDA-sponsored Join Together Graduate Fellows Institute, June 26-29, 1999 in Falmouth, MA.
Dr. Timothy P. Condon presented a keynote address, "NIDA: Researching the Health Effects of Smoked Drugs of Abuse" at the annual meeting of the Federation of American Societies for Experimental Biology, July 19, 1999 in Copper Mountain, CO.
Dr. Timothy P. Condon presented a keynote address, "Scientific Based Research," at the Executive Drug Prevention and Demand Reduction Symposium of the National Interagency Civil-Military Institute, July 21, 1999 in San Luis Obispo, CA.
Dr. Timothy P. Condon participated on a Federal panel at a national meeting of the Child Welfare League of America, August 7, 1999 in Portland, ME.
Dr. Timothy P. Condon chaired a symposium on "Research to Practice," at the International Congress on Alcohol and Drugs, August 17, 1999 in Vienna, Austria.
Dr. Timothy P. Condon addressed staff and executives of MTV during a briefing on accurate depiction of drugs in the media, August 19, 1999 in New York City.
On June 27, Beverly Wyckoff Jackson, Chief, Public Information and Liaison Branch, participated in the 1999 National Media Education conference sponsored by the Partnership for Media Education. Ms. Jackson was part of the planning committee for this conference and also conducted a presentation about outreach to the entertainment industry. NIDA was a cosponsor of the conference.
Dr. Tom Aigner, DBR, represented NIDA at The Second Bioengineering Consortium (BECON) symposium "Visualizing the Future of Biology and Medicine", held June 25-26, 1999 on the NIH campus in Bethesda, Maryland. NIDA grantees invited to present their latest research findings at the symposium were Nora Volkow of the Brookhaven National Laboratory who spoke on "Functional Imaging in the Early Detection of Disease" and Thomas Meade of the California Institute of Technology who spoke on "Design Issues for Novel Contrast Agents and Biological Probes". Posters were presented by: NIDA grantee Leonard Howell of Emory University on "Positron Emission Tomography Imaging in Awake Nonhuman Primates During Cocaine Use"; NIDA grantee Eric Ahrens of the California Institute of Technology on "Magnetic Resonance Microscopy of the Mouse Nervous Sstem at 12 Tesla"; Bruce Vaupel of the NIDA Intramural Research Program (IRP) on "In Vtro and in Vivo Evaluation of 5-[I-123]IODO-A-85380 as a Radiotracer for Single Photon Emission Computed Tomography Imaging of Nicotinic Acetylcholine Receptors"; Monique Ernst of the NIDA IRP on "Nicotine and Cerebral Blood Flow During a Working Memory Task"; and Patricia Janak of the NIDA IRP on "Spatiotemporal Maps of Brain Function: Using Ensemble Recording to Image Function in Behaving Animals".
On May 21, 1999, Mr. Joel Egertson, MDD hosted a meeting on Buprenorphine and Buprenorphine/Naloxone Products with representatives from 10 state governments and other medical and professional organizations. Presentations were made by Dr. Camille Barry of CSAT, Dr. Frank Vocci of MDD, Dr. Paul Fudala of the Philadelphia VAMC, and Dr. Paul Casadonte of the Manhattan VAMC regarding buprenorphine and buprenorphine /naloxone. Federal regulatory issues were discussed by Mr. Nick Reuter and Dr. Alan Trachtenberg of SAMHSA, and Ms. Denise Curry of DEA. Mr. Egertson spoke on current Federal legislative efforts. Following the morning presentations, Mr. Jack Gustafson of NASDAD moderated a discussion of the State's comments and concerns regarding implementation issues for this potential new opiate pharmacotherapy.
On July 14 -15, 1999, Dr. Lula Beatty, Chief, Special Populations Office, attended an HBCU Recruited Scientist Advisory Board meeting in Tallahassee, Florida.
On July 6-7, 1999, Dr. Lula Beatty, attended a technical assistance meeting sponsored by CSAP/SAMHSA for the project "Science Based Strategies for Alcohol Prevention at HBCUs" in Hilton Head, South Carolina.
On April 29-May 1, Dr. Lula Beatty was a keynote speaker for the Youth Science Fair at the Lonnie Mitchel HBCU conference. She also received a Lonnie Mitchel HBCU Award.
On May 20, 1999, Dr. Lula Beatty attended a Grantsmanship Workshop for faculty at Morgan State University in Baltimore, Maryland.
On July 27, 1999, as a representative of the Section on the Psychology of Black Women, APA, Dr. Lula Beatty was a reviewer for a small grant program for HIV/AIDS Interventions with Black Women.
On July 8-9, 1999, as a representative of the Special Populations Office, Arnold Mills, chaired a technical assistance workshop for faculty and staff of Historically Black Colleges and Universities (HBCUs) in Bethesda, Maryland. At the workshop, sponsored by the Special Populations Office, participants learned about the NIH research grants application and review processes, various funding mechanisms available through NIDA and NIH, and consulted with NIDA supported investigators about the research plans.
On July 8-9, 1999, Ana Anders, Senior Advisor on Special Populations, Special Populations Office, chaired a meeting of the National Hispanic Science Network (NHSN), formerly the Hispano/Latino Researchers and Scholars Work Group (HLRSWG). The mission of the NHSN is "to foster science on drug use among Hispanics and its application to practice and public health."
In July 1999, as a representative of NIDA, Ana Anders lectured to group of nine scholars who are faculty at Hispanic Serving Institutions (Institutions of higher learning that have over 25% Hispanic student enrollment).
Through the Hispanic Association of Colleges and Universities (HACU), the Special Populations Office sponsored Dr. Elba Herrero, a Hispanic Serving Institution faculty member for two weeks in July 1999. Under the guidance of Ana Anders, she learned of NIDA's operation.
In July 1999, Ana Anders held a meeting with NIDA staff to inform them of NIDA's plans to develop an Asian and Pacific Islander (API) initiative. At the meeting Ana Anders updated staff on NIDA's activities with respect to the API population and received advice from the group.
On July 30, 1999, as a representative of NIDA, Ana Anders made a presentation to a group of professional faculty of the Universities of Bolivia, Ecuador and Peru in Washington, D.C. The group was a part of the "Project to Assist Nursing Schools" program, conducted by the Organization of American States (OAS) and its component, the "Comision Interamericana para el Control del Abuso de Drogas" (CICAD).
On June 23-25, 1999, as a representative of NIDA, Ana Anders attended the Annual U.S./Mexico Demand Reduction Conference in Tijuana, Mexico.
On July 21-24, 1999, Ana Anders attended the National Asian and Pacific American Families Against Substance Abuse (NAPAFASA) conference in Los Angeles, California. At the conference, which was co-sponsored by NIDA, she met with NAPAFASA board members to identify research issues of concern to Asian and Pacific Islanders.
Jag H. Khalsa, Ph.D. of CAMCODA presented a review of the "Medical and Health Consequences of Marijuana and Its Uses for Medical Purposes" at the NIDA-supported FASEB Summer Conference in Copper Mountain, Colorado, July 18-23, 1999. He also co-chaired with Dr. Alex Makriyannis, a Workshop on "Therapeutic Potential of Cannabinoids…," where the speakers presented on the therapeutic potential of novel cannabinoids, pharmacological mechanisms, animal studies (Billy Martin), clinical trials (Don Abrams), and potential formulations and routes of administration (M. ElSohly).
Mr. Richard Harrison, Chief, Contracts Review Branch, presented a welcome and participated in an August meeting entitled "American Indian Research Training Needs" sponsored by NIH and the Indian Health Service.
OEPR and MDD hosted a training symposium, "From Bench to Pharmacy: Discovering and Developing Medications," on June 30. This session was attended by staff from NIDA, NIMH, and NINDS and focused on the regulatory, scientific, and administrative aspects of medications development. Organized by Drs. Betty Tai (MDD) and William C. Grace (OEPR), the symposium included talks on FDA procedures (Dr. Celia Winchell, FDA), Clinical Development (Dr. Betty Tai, MDD), Preclinical Development (Dr. James Terrill, MDD), Phamacokinetic and Pharmacodynamic issues (Dr. Nora Chiang, MDD), Tools for Collaboration with Drug Companies (Mr. Lee Cummings, MDD), and Review of Applications (Dr. Khursheed Asghar, OEPR).
Dr. Mark Swieter gave two talks at the annual meeting of the College on Problems of Drug Dependence (CPDD). One was for the workshop titled "Women, Gender and Behavioral Research: Focus on Early Career," which was organized by Drs. Cora Lee Wetherington (DBR) and Lynda Erinoff (DEPR). Dr. Swieter's presentation was "NIDA Training Opportunities for Junior Investigators." The second talk, "Demystifying the Review Process, or Inside the Black Box Called Review," was given as part of a grant writing workshop organized by Dr. Cindy Miner (OSPC).
Also at CPDD, Dr. Teri Levitin organized and chaired a workshop entitled "Update on the Grant Review Process, New Review Groups and Changes in Review Procedures at NIH".
On May 28, 1999, Dr. Frank Vocci, Director, MDD delivered a plenary lecture on the Neurobiology of Drug Dependence at the International Society for Magnetic Resonance in Medicine meeting in Philadelphia, PA.
On June 5, 1999, Dr. Frank Vocci spoke on medications development issues pertaining to buprenorphine and buprenorphine/naloxone at the NASADAD meeting in St. Petersburg, FL.
On June 11, 1999, Dr. Frank Vocci spoke on the Neurobiology of Drug Addiction at the NIDA International satellite meeting, " Building International Research on Drug Abuse: Continuing Focus on Children and Youth" in Acapulco, Mexico.
On July 14, 1999, Dr. Frank Vocci discussed the NIDA medications program history and current status at an NHLBI symposium on Medications Development for Rare Blood Disorders at the Lister Hill Center.
On August 6, 1999, Dr. Frank Vocci presented an Overview of the NIDA Medications Development Program at the FASEB Conference: Biological Vulnerability to Alcoholism and Drug Addiction held in Copper Mountain, Colorado.
Dr. Steven Grant, DCSR, presented a talk entitled "Activation of the Ventromedial Prefrontal Cortex Correlates with Gambling Task Performance: An FDG-PET Study" at the annual meeting of the College on Problems of Drug Dependence, June 11-17, 1999, in Acapulco, Mexico.
Dr. Harold Gordon attended the 40th Annual Short Course in Medical and Experimental Mammalian Genetics in Bar Harbor, ME, July 1999.
Dr. Harold Gordon organized, together with members of the Developmental Workgroup, a Workshop held on September 9, 1999 entitled, "Early Environmental Stress and Biological Vulnerability to Drug Abuse" held in Bethesda, Maryland.
Arthur MacNeill Horton, Jr., Ed.D. co-chaired with Minda Lynch, Ph.D. the symposium "Motives for Behavior: From Neurobiology to Cognitive Perspectives" which was presented at the American Psychological Society meeting in Denver, Colorado, on June 5, 1999.
Drs. Steven Grant and Joseph Frascella attended the Society of Biological Psychiatry annual meeting in Washington, DC, May 13-14, 1999.
Dr. Joseph Frascella made presentations on NIDA's neuroscience programs and on the NIH grant process at the NIDA Special Populations Research Development Seminar "Cannabinoids, Opiate Immunology and Estrogen Vascular Neuroimmunology" in Melville, Long Island, New York, June 22-25, 1999.
On May 19, 1999, Dr. Jack Blaine was a discussant for the symposium on Science-Based Behavioral Therapies for Drug Addiction at the American Psychiatric Association annual convention in Washington, D.C.
On March 17, 1999, Dr. Lisa Onken gave a presentation on NIDA treatment research and suicidal behavior at an NIMH-sponsored workshop, "Assessment and Treatment of Suicidal Behavior in Clinical Trials," in Washington, D.C.
On April 28, 1999, Dr. Lisa Onken gave a presentation on the behavioral therapy component in cocaine addiction medications development research at the CPDD/NIDA/FDA/NIAAA/SNRT Meeting on Clinical Outcomes in Washington, D.C.
On May 19, 1999, Dr. Lisa Onken chaired a symposium on Science-Based Behavioral Therapies for Drug Addiction at the American Psychiatric Association annual convention in Washington, D.C.
On May 27, 1999, Dr. Lisa Onken gave a presentation on the translation of basic behavioral and cognitive science into novel behavioral therapies to the NIMH Council Behavioral Science Workgroup, in Tysons Corner, Virginia.
On June 8, 1999, Dr. Elizabeth Rahdert participated in the Workshop on the Role of Co-occurring Substance Abuse and Mental Illness in Violence. The workshop, held in Washington, DC, was co-sponsored by the Board on Neuroscience and Behavioral Health, IOM, and the MacArthur Foundation.
On June 22, 1999, Dr. Elizabeth Rahdert conducted a POSIT (Problem Oriented Screening Instrument for Teenagers) Training Workshop for the 7th Annual Montgomery County Public Schools Safe & Drug-Free Schools Summer Institute, held in Rockville, Maryland.
On August 11-12, 1999, Dr. Elizabeth Rahdert participated in a meeting, sponsored by The Robert Wood Johnson Foundation, and held in Princeton, New Jersey, on the topic of "Restorative Justice Responses to Adolescent Substance Abuse." Meeting participants included professionals from the areas of juvenile justice and adolescent treatment.
On August 20, 1999, Dr. Elizabeth Rahdert chaired the symposium, "Promising Approaches to Treating Substance Abuse in High Risk Adolescents" at the 107th Annual Convention, American Psychological Association, Boston, MA. Symposium participants included NIDA grantees Dr. Peter Monti, "Reaching Adolescents Through Brief Motivational Interviewing for Smoking," Dr. Neil McGillicuddy, "Coping-Skills Training for Parents of Adolescent Drug Abusers," Dr. Robert Malow, "Cognitive-Behavioral Therapy to Reduce HIV Risk Among Drug Abusing Adolescents," and Dr. Arthur M. Horton, DCSR, NIDA, as discussant.
On August 31, 1999, Dr. Elizabeth Rahdert presented a poster presentation, "Development of an Adolescent HIV/STD Risk-of-Exposure Mini-Questionnaire," at the 1999 National HIV Prevention Conference held in Atlanta, Georgia.
On May 26-27, 1999, Debra Grossman, DCSR, participated in a Youth Tobacco Cessation Collaborative Workshop. Meeting participants represented a variety of organizations that fund activities related to youth tobacco-use cessation.
Dr. Bennett Fletcher, Chief, Services Research Branch, DCSR, made a presentation on "Research and Practice: Stimulating Interdependence" at the NASADAD Annual Meeting in Tampa, Florida on June 5, 1999.
Dr. Bennett Fletcher chaired a symposium on "Research on Linkages Between Drug Treatment and Other Systems of Care" at the Annual Meeting of the Association for Health Services Research (AHSR) held in Chicago on June 26, 1999.
Dr. Bennett Fletcher made a presentation on research funding opportunities in health services research at the Annual Meeting of the AHSR held in Chicago on June 27, 1999.
Dr. Bennett Fletcher chaired a panel on "Bridging the Gap: Bringing Drug Abuse Treatment From Research to Practice" at the Annual Meeting of the AHSR held in Chicago on June 28, 1999.
Dr. Peter Delany co-chaired the NIDA-NDRI meeting on "HIV/AIDS in Drug Abuse Treatment Settings: Expanding Research & Practice", held March 25-26, 1999 in Bethesda, Maryland.
Dr. Peter Delany made a presentation on research funding opportunities to the Alcohol, Tobacco, and Other Drugs Section of the National Association of Social Workers, May 8, 1999 in New York City.
Dr. William S. Cartwright, SRB, DCSR presented a paper "The Economics of Public Health: Financing Drug Abuse Treatment Services." (with Dr. Paul Solano, University of Delaware) at the Western Economics Association International meeting held in San Diego, July 9, 1999.
Dr. Jerry Flanzer, SRB, DCSR spoke about NIDA's interest, current funding and related findings concerning co-occurring mental health and substance abuse disorders at the Multiple Disorders, Multiple Perspective Conference held by MCP Hahnemann University, Philadelphia, April 28-30, 1999.
Dr. Jerry Flanzer, SRB, DCSR moderated a panel/workshop on "Solutions Based Addiction Treatment", and assisted new investigators and doctoral candidates address applying to NIH for support at the Annual Addictions Institute, Addictions Through the Life Cycle Conference of the Alcohol, Tobacco and other Drugs Section of the National Association of Social Workers, at Fordham University, New York, May, 7-8, 1999.
Dr. Jerry Flanzer, SRB, DCSR co-led two workshops on "Substance Abuse Treatment within ASFA (Adoption and Safe Families Act) Timelines" at the Administration for Children and Families-Region V conference " Honoring the Promise of Permanency," Chicago, Ill. May 11-12, 1999.
Dr. Jerry Flanzer, SRB, DCSR presented a talk entitled "Working With Clients With Substance Abuse Issues-New Research Findings in the Field of Drug Abuse Research that Effects Decisions for Child Protection Workers" at the child abuse and neglect discretionary grant meeting of the Children's Bureau, Administration for Children, Youth and Families, June 3, 1999.
Dr. Jerry Flanzer, SRB, DCSR participated as an advisor/teacher in the Institute for the Advancement of Social Work Research's Ph.D. Dissertation Research Technical Assistance Workshop at IASWR's headquarters on June 4, 1999.
Dr. Jerry Flanzer represented SRB, DCSR at the Institute of Medicine's Meeting of Co-Occurring Disorders, Washington, D.C., June 8, 1999.
Dr. Jerry Flanzer and Dr. Tom Hilton represented SRB, DCSR at the 16th Annual Meeting of the Association of Health Services Research, Chicago IL on June 25-29, 1999.
Dr. Meyer Glantz (DEPR) was a panel participant and copresenter at the Center for Mental Health Services Resilience Conference, June 17 & 18, 1999 in Chantilly, Virginia.
Dr. William J. Bukoski, DEPR, served as the program conference chair for the 1999 Annual Meeting of the Society for Prevention Research (SPR) which was held June 24-26, 1999, New Orleans, LA.
Dr. Bukoski, DEPR, with Dr. Minda Lynch, DBR, co-chaired a scientific symposium on the topic of "The Integration of Basic Research and Prevention Science" at the 1999 Annual Meeting of the Society for Prevention Research. The session was titled: "Pre-clinical, Clinical, and Preventive Perspectives on Protection and Liability to Drug Abuse and Mental Disorders."
Dr. Bukoski, also helped plan and co-chair two additional symposia at SPR. The titles of these symposia were: "Innovations in Training at Mental Health, AIDS, Drug Prevention Research, and Alcohol Prevention Research Centers," and "Just Say 'huh'? Integrating Indicated Prevention with Primary and Selective Substance Abuse Prevention Programming."
Drs. Kathy Etz and Elizabeth Robertson represented NIDA at the Society for Prevention Research in June, 1999. As part of the behavioral sciences work group tour, they led a session highlighting the research of early career investigators, mentoring advice from a senior investigator, and mechanisms to support early career investigators. Drs. Tony Biglan and Phil Fisher presented as part of the session.
Susan David, Jacques Normand, and Elizabeth Robertson hosted an agenda setting meeting titled Drugs and the Workplace on May 3 and 4, 1999. Researchers and representatives from multiple government agencies discussed new directions for research. A document summarizing the outcomes of the meeting is in preparation.
Arnold Mills, M.S.W., organized and chaired the Technical Assistance Workshop for Faculty and Staff from Historically Black Colleges and Universities, in Bethesda, MD, July 8-9, 1999. The purpose of the workshop was to provide an overview of funding mechanisms at NIH and information on proposal plan development, to review elements of a well-written proposal, and to discuss the proposal assessment process.
Richard Needle, Ph.D., Chief, Community Research Branch, DEPR, moderated two panels at the Centers for Disease Control and Prevention's National HIV Prevention Conference in Atlanta, Georgia, August 29-September 1, 1999. The first panel was on "HIV Prevention Interventions with Demonstrated Evidence of Effectiveness in Injecting Drug Users" and the second was a panel of international researchers on the topic of "Global Perspectives on Epidemiology and HIV Prevention in Drug-Using Populations."
Jacques Normand, Ph.D., CRB, DEPR presented a poster on research agendas and funding opportunities at the annual meeting of the American Sociological Association held in Chicago, IL, August 6-10, 1999.
Dr. Kathy Etz presented a poster co-authored with Drs. Robertson, Colliver and Glantz at the Society for Research on Child Development. The poster was entitled: The Gateway Theory of Adolescent Drug Use. The meeting was held in Albuquerque, New Mexico.
Dr. Elizabeth Robertson is representing NIDA on the Alcohol Coordination Team of the United States Public Health Services Guide to Community Preventive Service. The lead agencies for the coordination team are SAMHSA and CDC.
Dr. Jean Lud Cadet, Molecular Neuropsychiatry Section, NIDA IRP, presented a talk entitled "The Role of Free Radicals in METH-induced Neurotoxicity: Implications for Parkinsonism" at NIH, in June 1999.
Dr. Jean Lud Cadet, Molecular Neuropsychiatry Section, NIDA IRP, presented a talk entitled "The Role of Free Radicals and Death-Related Genes in METH-induced Apoptosis" at NIDA Headquarters, in July 1999.
Dr. Jonathan Katz presented a paper entitled: "The Dopamine Transporter Hypothesis of Cocaine Effects" at the FASEB Summer Conference on Biological Vulnerability to Alcoholism and Drug Addiction.
Dr. David Gorelick presented an invited lecture on "Interrelationships among Tobacco, Marijuana, and Cocaine Smoking" at the 1999 FASEB Summer Research Conference on Pulmonary Pathophysiologic and Immune Consequences of Smoked Substance Abuse, Copper Mountain, CO, July 18-23, 1999.
Dr. D. Bruce Vaupel presented "In Vitro and In Vivo Evaluation of 5-[I-123]iodo-A-85380 as a Radiotracer for Single Photon Emission Computed Tomography Imaging of Nicotinic Acetylcholine Receptors" at the Biomedical Imaging Symposium "Visualizing the Future of Biology and Medicine", Bethesda, MD, June 25-26, 1999.
Dr. Monique Ernst presented "High-Resolution Noninvasive Vascular Imaging Using Real-Time Magnetic Resonance Imaging Techniques" at the Biomedical Imaging Symposium "Visualizing the Future of Biology and Medicine", Bethesda, MD, June 25-26, 1999.
Dr. Monique Ernst presented "Nicotine and Cerebral Blood Flow During a Working Memory Task" at the Biomedical Imaging Symposium "Visualizing the Future of Biology and Medicine", Bethesda, MD, June 25-26, 1999.
"Pharmacokinetics of Liquid Vs Tablet Buprenorphine" K. Ajir, N. Chiang, and W. Ling, Presented at the 61st Annual Scientific Meeting of the College on Problems of Drug Dependence, 13 June 1999, Acapulco, Mexico.
"How to Use Quantitative Benzoylecgonine Levels for the Interpretation of Cocaine Usage in Clinical Trials" C.N. Chiang, S.H. Li, B. Tai, C. Marschke, K.L. Preston, R.L. Hawks, and F. Vocci, Presented at the 61st Annual Scientific Meeting of the College on Problems of Drug Dependence, 13 June 1999, Acapulco, Mexico.
"The Effect of Chronic Cocaine Use on MAO and COMT Activities in the Human Brain: A Postmortem Study". A. Elkashef, D. Mash, G. Eisenhofer, S. Izenwasser, J. Pablo, T. Bridge, and F. Vocci, Presented at the 61st Annual Scientific Meeting of the College on Problems of Drug Dependence, 13 June 1999, Acapulco, Mexico.
"Inpatient Evaluation for the Tolerability of High Dose Dextromethorphan in Methadone-Maintained Subjects" B.H. Herman, J.W. Cornish, R.N. Ehrman, A.R. Rose, V. Bead, C. Hackett, K. Martz, F.S. Caruso, F. Vocci, and C.P. O'Brien, Presented at the 61st Annual Scientific Meeting of the College on Problems of Drug Dependence, 13 June 1999, Acapulco, Mexico.
"Inpatient Safety Evaluation of Lofexidine, An Alpha-2 Adrenergic Agonist As A Medication for Opiate Withdrawal" E. Yu, B.H. Herman, K. Miotto, A. Montgomery, P.J. Fudala, C. Fisher, C.N. Chiang, W. McFadden, K. Kampman, V. Dhopesh, J. Cornish, B. Walsh, K. Davies, F. Vocci, W. Ling, C.P. O'Brien, Presented at the 61st Annual Scientific Meeting of the College on Problems of Drug Dependence, 13 June 1999, Acapulco, Mexico.
of the Director][Report Index][Previous
Report Section] [Next Report Section]